To mix or not to mix in lupus anticoagulant testing? That is the question

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Mixing patient and normal plasma has been used for many years to assist with making decisions on which direction to proceed for further investigation of abnormally prolonged coagulation tests, namely, either individual coagulation factor measurement or the search for circulating anticoagulants. Mixing tests, however, gained wide acceptance only after the so-called lupus-like anticoagulant (LA) phenomenon was described and were, therefore, included in the guidelines for LA detection issued by the working group of the International Society on Thrombosis and Haemostasis. Important though they may be considered, the dispute between those who advocate the use of mixing tests and those who deny their superiority (or their need) for LA detection is difficult to resolve. This article aims to provide a balanced view on this dispute. Based on the limited information provided by the literature one may conclude that the disadvantages of performing mixing studies are the fact that (1) they are time-consuming; (2) they require a suitable source of normal pool plasma; and (3) weak LA may be lost at diagnosis due to the dilution of index plasma into normal pooled plasma. On the contrary, performing mixing tests makes the occurrence of false-negative LA in patients who present with the so-called "lupus cofactor phenomenono" relatively unlikely and, therefore, justifies their performance even though the frequency of the occurrence of this phenomenon in LA-positive patients is still unknown.

Original languageEnglish
Pages (from-to)385-389
Number of pages5
JournalSeminars in Thrombosis and Hemostasis
Volume38
Issue number4
DOIs
Publication statusPublished - 2012

Fingerprint

Lupus Coagulation Inhibitor
Anticoagulants
Dissent and Disputes
Blood Coagulation Factors
Hemostasis
Decision Making
Thrombosis
Guidelines

Keywords

  • anticoagulant testing
  • coagulation
  • lupus-like anticoagulants
  • mixing tests

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

To mix or not to mix in lupus anticoagulant testing? That is the question. / Tripodi, Armando.

In: Seminars in Thrombosis and Hemostasis, Vol. 38, No. 4, 2012, p. 385-389.

Research output: Contribution to journalArticle

@article{a7e4a316a6124f7fba9c271f6554249a,
title = "To mix or not to mix in lupus anticoagulant testing? That is the question",
abstract = "Mixing patient and normal plasma has been used for many years to assist with making decisions on which direction to proceed for further investigation of abnormally prolonged coagulation tests, namely, either individual coagulation factor measurement or the search for circulating anticoagulants. Mixing tests, however, gained wide acceptance only after the so-called lupus-like anticoagulant (LA) phenomenon was described and were, therefore, included in the guidelines for LA detection issued by the working group of the International Society on Thrombosis and Haemostasis. Important though they may be considered, the dispute between those who advocate the use of mixing tests and those who deny their superiority (or their need) for LA detection is difficult to resolve. This article aims to provide a balanced view on this dispute. Based on the limited information provided by the literature one may conclude that the disadvantages of performing mixing studies are the fact that (1) they are time-consuming; (2) they require a suitable source of normal pool plasma; and (3) weak LA may be lost at diagnosis due to the dilution of index plasma into normal pooled plasma. On the contrary, performing mixing tests makes the occurrence of false-negative LA in patients who present with the so-called {"}lupus cofactor phenomenono{"} relatively unlikely and, therefore, justifies their performance even though the frequency of the occurrence of this phenomenon in LA-positive patients is still unknown.",
keywords = "anticoagulant testing, coagulation, lupus-like anticoagulants, mixing tests",
author = "Armando Tripodi",
year = "2012",
doi = "10.1055/s-0032-1304717",
language = "English",
volume = "38",
pages = "385--389",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - To mix or not to mix in lupus anticoagulant testing? That is the question

AU - Tripodi, Armando

PY - 2012

Y1 - 2012

N2 - Mixing patient and normal plasma has been used for many years to assist with making decisions on which direction to proceed for further investigation of abnormally prolonged coagulation tests, namely, either individual coagulation factor measurement or the search for circulating anticoagulants. Mixing tests, however, gained wide acceptance only after the so-called lupus-like anticoagulant (LA) phenomenon was described and were, therefore, included in the guidelines for LA detection issued by the working group of the International Society on Thrombosis and Haemostasis. Important though they may be considered, the dispute between those who advocate the use of mixing tests and those who deny their superiority (or their need) for LA detection is difficult to resolve. This article aims to provide a balanced view on this dispute. Based on the limited information provided by the literature one may conclude that the disadvantages of performing mixing studies are the fact that (1) they are time-consuming; (2) they require a suitable source of normal pool plasma; and (3) weak LA may be lost at diagnosis due to the dilution of index plasma into normal pooled plasma. On the contrary, performing mixing tests makes the occurrence of false-negative LA in patients who present with the so-called "lupus cofactor phenomenono" relatively unlikely and, therefore, justifies their performance even though the frequency of the occurrence of this phenomenon in LA-positive patients is still unknown.

AB - Mixing patient and normal plasma has been used for many years to assist with making decisions on which direction to proceed for further investigation of abnormally prolonged coagulation tests, namely, either individual coagulation factor measurement or the search for circulating anticoagulants. Mixing tests, however, gained wide acceptance only after the so-called lupus-like anticoagulant (LA) phenomenon was described and were, therefore, included in the guidelines for LA detection issued by the working group of the International Society on Thrombosis and Haemostasis. Important though they may be considered, the dispute between those who advocate the use of mixing tests and those who deny their superiority (or their need) for LA detection is difficult to resolve. This article aims to provide a balanced view on this dispute. Based on the limited information provided by the literature one may conclude that the disadvantages of performing mixing studies are the fact that (1) they are time-consuming; (2) they require a suitable source of normal pool plasma; and (3) weak LA may be lost at diagnosis due to the dilution of index plasma into normal pooled plasma. On the contrary, performing mixing tests makes the occurrence of false-negative LA in patients who present with the so-called "lupus cofactor phenomenono" relatively unlikely and, therefore, justifies their performance even though the frequency of the occurrence of this phenomenon in LA-positive patients is still unknown.

KW - anticoagulant testing

KW - coagulation

KW - lupus-like anticoagulants

KW - mixing tests

UR - http://www.scopus.com/inward/record.url?scp=84861343727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861343727&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1304717

DO - 10.1055/s-0032-1304717

M3 - Article

C2 - 22618530

AN - SCOPUS:84861343727

VL - 38

SP - 385

EP - 389

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 4

ER -